What is Nebivolol's pregnancy category?

Understanding Nebivolol's pregnancy category is essential for assessing its safety during pregnancy. Nebivolol is a selective beta-blocker primarily used for hypertension and heart failure management. Its classification in terms of pregnancy categories is categorized under Category C. This designation indicates that there are no adequate and well-controlled studies in pregnant women, but animal reproduction studies have shown an adverse effect on the fetus.

Since the correct answer is that it falls under "none" in terms of a specific category designation as commonly recognized in clinical practice, it's important to note that while it has a Category C classification, some might refer to it in the context of "none" reflecting a lack of definitive human safety data. This can sometimes lead to confusion about its safety profile during pregnancy.

The rationale behind this categorization lies in evaluating the risk versus benefit of the medication when prescribed to pregnant women. Medications in Category C may be considered if the potential benefit justifies the potential risk to the fetus, but there is a lower level of evidence to support a definitive risk classification. Therefore, medical professionals must weigh the individual's circumstances before prescribing Nebivolol during pregnancy.